“…Consistent with previous studies (Basun et al, 1995;Bondi et al, 1999;Corder et al, 1995;Normann et al, 1995;Dal Forno et al, 1996;DeKosky et al, 1995;Gomez-Isla et al, 1996;Growdon et al, 1996;Kurz et al, 1996;Small et al, 1998;Smith et al, 1998), there was little overall effect of APOE genotype on the cognitive performance of the NC participants or AD patients in the Very-Old or Young-Old cohorts (e.g., no main effect of APOE genotype in the multivariate analysis and in all but one of the ANOVAs). However, there were interactions between age and the presence of the APOE ε4 allele on the severity of impairment exhibited by patients with AD on some measures of memory, visuomotor sequencing, and perseverative responding, but these interaction effects were not consistent across measures.…”